Literature DB >> 15471094

Use of biomarkers to characterize functions of polymorphic DNA repair genotypes.

William W Au1, Panida Navasumrit, Mathuros Ruchirawat.   

Abstract

Inheritance of variant DNA repair genes is believed to influence individual susceptibility to the development of environmental cancer. However, the validity of the belief is dependent upon understanding the functions of the variant genes. Consequently, a variety of studies have been conducted to investigate the functions of variant DNA repair genes, e.g. using biomarkers. These studies on several representative polymorphic DNA repair genes are reviewed in this report. From a general overview, it appears that the biomarker investigations did not provide consistent observations. However, from a more careful evaluation, it is clear that the inconsistencies are probably caused by the use of populations and biomarkers that are not appropriate for investigating the repair activities of the genes. For example, the use of cigarette smokers and patients may not generate precise information for this type of investigations because these conditions can modify the functions of the investigated genes. Thus, the use of healthy non-smokers would be more appropriate. Other problems with these studies includes the small sample size used and the fact that some of the biomarkers used, such as sister chromatid exchanges, are not appropriate because the mechanisms for formation of the biomarkers and their biological significance are unknown. Nevertheless, the following conclusions can be derived from the review of the various biomarker studies that have been published. XRCC1 194Trp, OGG1 326Cys and APE1 148Glu probably have limited alterations in repair activities compared to the wild-type genotypes. XRCC1 399Gln and XRCC3 241Met are deficient in the repair of X-ray-, but not UV-light-induced chromosome aberrations, therefore the variant genes are defective in base excision repair. XPD 312Asn and XPD 751Gln are deficient in the repair of UV-light- but not X-ray-induced chromosome aberrations, therefore they are defective in nucleotide excision repair.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471094     DOI: 10.1078/1438-4639-00294

Source DB:  PubMed          Journal:  Int J Hyg Environ Health        ISSN: 1438-4639            Impact factor:   5.840


  19 in total

1.  Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer.

Authors:  Mary A Bewick; Robert M Lafrenie; Michael S C Conlon
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-28       Impact factor: 4.553

2.  Predictive effect of XRCC3 Thr241Met polymorphism on platinum-based chemotherapy in lung cancer patients: meta-analysis.

Authors:  Wei Zhang; Bo Yan; Liyan Jiang
Journal:  Tumour Biol       Date:  2013-08-30

3.  Influence of polymorphisms at loci encoding DNA repair proteins on cancer susceptibility and G2 chromosomal radiosensitivity.

Authors:  Craig S Wilding; Gillian B Curwen; E Janet Tawn; Xiaohua Sheng; Jeanette F Winther; Ranajit Chakraborty; John D Boice
Journal:  Environ Mol Mutagen       Date:  2007-01       Impact factor: 3.216

4.  XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies.

Authors:  Da-Peng Ding; Wen-Li Ma; Xiao-Feng He; Ying Zhang
Journal:  Mol Biol Rep       Date:  2011-06-11       Impact factor: 2.316

5.  Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.

Authors:  Kai-Ge Wu; Xiao-Feng He; Yun-Hui Li; Wei-Bin Xie; Xi Huang
Journal:  Tumour Biol       Date:  2014-08-13

6.  Polymorphism in XRCC1 gene modulates survival and clinical outcomes of advanced North Indian lung cancer patients treated with platinum-based doublet chemotherapy.

Authors:  Amrita Singh; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal:  Med Oncol       Date:  2017-03-22       Impact factor: 3.064

7.  Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.

Authors:  Randa El-Zein; Claudia M Monroy; Carol J Etzel; Andrea C Cortes; Yun Xing; Amanda L Collier; Sara S Strom
Journal:  Cancer       Date:  2009-04-15       Impact factor: 6.860

8.  A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility.

Authors:  Fang Wen; Zhiyong Zhao; Chuan Liu; Qinghua Yin; Jie Weng; Yajie Wang; Yuchen Ma
Journal:  Tumour Biol       Date:  2014-04

9.  XRCC1 and XRCC3 variants and risk of glioma and meningioma.

Authors:  Anne Kiuru; Carita Lindholm; Sirpa Heinävaara; Taina Ilus; Päivi Jokinen; Hannu Haapasalo; Tiina Salminen; Helle Collatz Christensen; Maria Feychting; Christoffer Johansen; Stefan Lönn; Beatrice Malmer; Minouk J Schoemaker; Anthony J Swerdlow; Anssi Auvinen
Journal:  J Neurooncol       Date:  2008-06       Impact factor: 4.130

10.  Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population.

Authors:  Amit Kumar Mitra; Neetu Singh; Vivek Kumar Garg; Rashmi Chaturvedi; Mandira Sharma; Srikanta Kumar Rath
Journal:  J Exp Clin Cancer Res       Date:  2009-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.